TickerFacts.

Aytu Biopharma, Inc (AYTU): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$3.93M
Year ended 2026-06-30
$6.72M2024-06-30: $6.72M2025-06-30: $5.38M2026-06-30: $3.93M$3.93M
2024-06-30 Depreciation & Amortization (USD) 2026-06-30
Period endedDepreciation & AmortizationChange YoYSource filing
2026-06-30$3.93M-26.9%2026-09-22, From 2025-07-01
2025-06-30$5.38M-20.0%2026-09-22, From 2024-07-01
2024-06-30$6.72Mn/a2025-09-23, From 2023-07-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Aytu Biopharma, Inc (AYTU)2026-06-30$3.93M-26.9%
Nektar Therapeutics (NKTR)2025-12-31$1.03M-76.6%
Integrated Biopharma Inc (INBP)2025-06-30$318.0K+3.6%
Nuvation Bio Inc. (NUVB)2025-12-31$1.74M+154.6%
Ocular Therapeutix, Inc (OCUL)2025-12-31$4.32M+14.2%
Enanta Pharmaceuticals Inc (ENTA)2025-09-30$4.59M+96.3%
Lexicon Pharmaceuticals, Inc. (LXRX)2025-12-31$621.0K+16.3%
Spero Therapeutics, Inc. (SPRO)2025-12-31$0-100.0%
Gossamer Bio, Inc. (GOSS)2025-12-31$24.0K-97.1%

Compare AYTU, NKTR, INBP, NUVB side by side · Screen every company in Pharmaceutical Preparations ↗